SLC7A5 and melanoma: To date, there has been no report on using the prodrug approach for LAT1-mediated delivery of melanoma treatment molecules; hence, this study aimed to demonstrate and apply the LAT1-mediated delivery prodrug approach to improve intracellular sesamol uptake and, as a consequence, antiproliferation against melanoma cells.